SYNTHIA is attending the European Hematology Association (EHA) 2026 Congress, taking place 11–14 June 2026 in Stockholm, Sweden.
The annual EHA Congress is one of the leading global meetings for hematology research, bringing together scientists, clinicians, and innovators working across blood disorders and hematologic malignancies.
During the congress, SYNTHIA representatives aim to connect with members of the multiple myeloma (MM) and diffuse large B-cell lymphoma (DLBCL) scientific communities to introduce SYNTHIA. These 2 disease areas are part of SYNTHIA’s use cases, where we explore how synthetic data generation can benefit research, model development, and responsible data sharing while protecting patient privacy.
About the conference
The European Hematology Association (EHA) Congress is an international forum for sharing advances in the understanding, diagnosis, and treatment of hematologic diseases. Each year, the congress brings together experts from academia, healthcare, and industry to present cutting-edge research and foster collaboration across the global hematology community.
